Korro Bio KRRO
NASDAQ KRRO
$9.64 -0.07 (-0.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Return on Invested Capital [ROIC] (2021 - 2022)

Updated

Korro Bio's Return on Invested Capital [ROIC] came in at -974.45% for Q4 2022, down 849.87 percentage points from -124.58% a year earlier and down 891.54 percentage points from the prior quarter.

Analysis

Korro Bio (KRRO) Return on Invested Capital [ROIC] (2021 - 2022) Analysis & Trends

For FY2021, Korro Bio's Return on Invested Capital [ROIC] was -93.22%, down 78.53 percentage points from FY2020.

  • Going back by year, Return on Invested Capital [ROIC] was -14.69% in FY2020.
  • Business Quant data shows KRRO's Return on Invested Capital [ROIC] at -82.91% (Q3 2022), -76.20% (Q2 2022) and -173.38% (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Korro Bio 141.76 Mn -254.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -974.45%
Sep 30, 2022 -82.91%
Jun 30, 2022 -76.20%
Mar 31, 2022 -173.38%
Dec 31, 2021 -124.58%
Sep 30, 2021 -42.51%
Mar 31, 2021 -21.05%
API Access

Korro Bio Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=KRRO&period=max&api_key=YOUR_API_KEY